Nivolumab 240mg/24ml solution for infusion vials
NHS hospitals in England used £167,894,906 of indicative cost of Nivolumab 240mg/24ml solution for infusion vials in the 12 months to April 2026, about 0.7% of all hospital medicines spend. That is down 22.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nivolumab 240mg/24ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nivolumab 240mg/24ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £18,075,545 |
| Univ Hpl B/Ham Nhs Foundation Trust | £6,908,992 |
| Royal Surrey County Hosp Nhs Found Trust | £5,694,960 |
| Cambridge Univ Hosp Nhs Foundation Trust | £4,794,693 |
| Leeds Teaching Hpls Nhs Trust | £4,616,966 |
| The Christie Nhs Foundation Trust | £4,581,639 |
| Sheffield Teaching Hospitals Nhs Trust | £4,528,760 |
| Guy's & St Thomas' Nhs Foundation Trust | £4,233,864 |
| South Tees Hosp Nhs Foundation Trust | £4,150,925 |
| Nottingham University Hospitals Trust | £3,999,527 |
The primary-care picture
Nivolumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nivolumab medicine page.